These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 11169537)
21. Dermal penetration of propylene glycols: measured absorption across human abdominal skin in vitro and comparison with a QSAR model. Fasano WJ; ten Berge WF; Banton MI; Heneweer M; Moore NP Toxicol In Vitro; 2011 Dec; 25(8):1664-70. PubMed ID: 21782927 [TBL] [Abstract][Full Text] [Related]
22. In vitro human epidermal penetration of 1-bromopropane. Frasch HF; Dotson GS; Barbero AM J Toxicol Environ Health A; 2011; 74(19):1249-60. PubMed ID: 21830855 [TBL] [Abstract][Full Text] [Related]
23. Diffusion modeling of percutaneous absorption kinetics. 1. Effects of flow rate, receptor sampling rate, and viable epidermal resistance for a constant donor concentration. Anissimov YG; Roberts MS J Pharm Sci; 1999 Nov; 88(11):1201-9. PubMed ID: 10564070 [TBL] [Abstract][Full Text] [Related]
24. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement. Aboofazeli R; Zia H; Needham TE Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202 [TBL] [Abstract][Full Text] [Related]
25. Effect of chemical interactions in pentachlorophenol mixtures on skin and membrane transport. Baynes RE; Brooks JD; Mumtaz M; Riviere JE Toxicol Sci; 2002 Oct; 69(2):295-305. PubMed ID: 12377978 [TBL] [Abstract][Full Text] [Related]
26. Percutaneous absorption of steroids from finite doses: Predicting urinary excretion from in vitro skin permeation testing. Liu X; Cheruvu HS; Anissimov YG; van der Hoek J; Tsakalozou E; Ni Z; Ghosh P; Grice JE; Roberts MS Int J Pharm; 2022 Sep; 625():122095. PubMed ID: 35961420 [TBL] [Abstract][Full Text] [Related]
27. In vitro dermal absorption rate testing of certain chemicals of interest to the Occupational Safety and Health Administration: summary and evaluation of USEPA's mandated testing. Fasano WJ; McDougal JN Regul Toxicol Pharmacol; 2008 Jul; 51(2):181-94. PubMed ID: 18501488 [TBL] [Abstract][Full Text] [Related]
28. Interaction of hydration, aging, and carbon content of soil on the evaporation and skin bioavailability of munition contaminants. Reifenrath WG; Kammen HO; Reddy G; Major MA; Leach GJ J Toxicol Environ Health A; 2008; 71(8):486-94. PubMed ID: 18338283 [TBL] [Abstract][Full Text] [Related]
29. Analysis, interpretation, and extrapolation of dermal permeation data using diffusion-based mathematical models. Krüse J; Golden D; Wilkinson S; Williams F; Kezic S; Corish J J Pharm Sci; 2007 Mar; 96(3):682-703. PubMed ID: 17080423 [TBL] [Abstract][Full Text] [Related]
30. Prediction of formulation effects on dermal absorption of topically applied ectoparasiticides dosed in vitro on canine and porcine skin using a mixture-adjusted quantitative structure permeability relationship. Riviere JE; Brooks JD; Collard WT; Deng J; de Rose G; Mahabir SP; Merritt DA; Marchiondo AA J Vet Pharmacol Ther; 2014 Oct; 37(5):435-44. PubMed ID: 24649911 [TBL] [Abstract][Full Text] [Related]
31. Predicting skin penetration of actives from complex cosmetic formulations: an evaluation of inter formulation and inter active effects during formulation optimization for transdermal delivery. Wiechers JW; Watkinson AC; Cross SE; Roberts MS Int J Cosmet Sci; 2012 Dec; 34(6):525-35. PubMed ID: 22950455 [TBL] [Abstract][Full Text] [Related]
32. Model analysis of flux enhancement across hairless mouse skin induced by chemical permeation enhancers. He N; Warner KS; Higuchi WI; Li SK Int J Pharm; 2005 Jun; 297(1-2):9-21. PubMed ID: 15907593 [TBL] [Abstract][Full Text] [Related]
33. A new method for estimating dermal absorption from chemical exposure. 3. Compared with steady-state methods for prediction and data analysis. Bunge AL; Cleek RL; Vecchia BE Pharm Res; 1995 Jul; 12(7):972-82. PubMed ID: 7494817 [TBL] [Abstract][Full Text] [Related]
34. Methods for in vitro percutaneous absorption studies. VII: Use of excised human skin. Bronaugh RL; Stewart RF; Simon M J Pharm Sci; 1986 Nov; 75(11):1094-7. PubMed ID: 3820104 [TBL] [Abstract][Full Text] [Related]
35. Vehicle effects on human stratum corneum absorption and skin penetration. Zhang A; Jung EC; Zhu H; Zou Y; Hui X; Maibach H Toxicol Ind Health; 2017 May; 33(5):416-425. PubMed ID: 27436841 [TBL] [Abstract][Full Text] [Related]
36. A multiphase microscopic diffusion model for stratum corneum permeability. II. Estimation of physicochemical parameters, and application to a large permeability database. Wang TF; Kasting GB; Nitsche JM J Pharm Sci; 2007 Nov; 96(11):3024-51. PubMed ID: 17876780 [TBL] [Abstract][Full Text] [Related]
37. Modeling the effect of experimental variables on the in vitro permeation of six model compounds across porcine skin. Karadzovska D; Brooks JD; Riviere JE Int J Pharm; 2013 Feb; 443(1-2):58-67. PubMed ID: 23313919 [TBL] [Abstract][Full Text] [Related]
38. Skin penetration of nonsteroidal antiinflammatory drugs out of a lipophilic vehicle: influence of the viable epidermis. Wenkers BP; Lippold BC J Pharm Sci; 1999 Dec; 88(12):1326-31. PubMed ID: 10585230 [TBL] [Abstract][Full Text] [Related]
39. The influence of water mixtures on the dermal absorption of glycol ethers. Traynor MJ; Wilkinson SC; Williams FM Toxicol Appl Pharmacol; 2007 Jan; 218(2):128-34. PubMed ID: 17173944 [TBL] [Abstract][Full Text] [Related]
40. Effects of solvents on skin absorption of nonvolatile lipophilic and polar solutes under finite dose conditions. Intarakumhaeng R; Wanasathop A; Li SK Int J Pharm; 2018 Jan; 536(1):405-413. PubMed ID: 29180256 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]